These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8603281)

  • 1. Individual differences in central nervous system response to antihistamines (H1-receptor antagonists).
    Simons FE; Fraser TG; Reggin JD; Simons KJ
    Ann Allergy Asthma Immunol; 1995 Dec; 75(6 Pt 1):507-14. PubMed ID: 8603281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system effects of H1-receptor antagonists in the elderly.
    Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the central nervous system effects produced by six H1-receptor antagonists.
    Simons FE; Fraser TG; Reggin JD; Simons KJ
    Clin Exp Allergy; 1996 Sep; 26(9):1092-7. PubMed ID: 8889266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
    Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
    J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse central nervous system effects of older antihistamines in children.
    Simons FE; Fraser TG; Reggin JD; Roberts JR; Simons KJ
    Pediatr Allergy Immunol; 1996 Feb; 7(1):22-7. PubMed ID: 8792380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihistamines, drowsiness, and psychomotor impairment: central nervous system effect of cetirizine.
    Gengo FM; Gabos C
    Ann Allergy; 1987 Dec; 59(6 Pt 2):53-7. PubMed ID: 2892451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists.
    Witek TJ; Canestrari DA; Miller RD; Yang JY; Riker DK
    Ann Allergy Asthma Immunol; 1995 May; 74(5):419-26. PubMed ID: 7749974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
    Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
    Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention (TOVA).
    Mansfield L; Mendoza C; Flores J; Meeves SG
    Ann Allergy Asthma Immunol; 2003 May; 90(5):554-9. PubMed ID: 12775138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments.
    García-Gea C; Martínez-Colomer J; Antonijoan RM; Valiente R; Barbanoj MJ
    J Clin Psychopharmacol; 2008 Dec; 28(6):675-85. PubMed ID: 19011437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effects between rupatadine 10 mg and placebo on actual driving performance of healthy volunteers.
    Vuurman E; Theunissen E; van Oers A; van Leeuwen C; Jolles J
    Hum Psychopharmacol; 2007 Jul; 22(5):289-97. PubMed ID: 17599335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study.
    Ng KH; Chong D; Wong CK; Ong HT; Lee CY; Lee BW; Shek LP
    Pediatrics; 2004 Feb; 113(2):e116-21. PubMed ID: 14754980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers.
    Barbanoj MJ; García-Gea C; Morte A; Izquierdo I; Pérez I; Jané F
    Neuropsychobiology; 2004; 50(4):311-21. PubMed ID: 15539863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central effects of the H1-antihistamine, cetirizine.
    Nicholson AN; Turner C
    Aviat Space Environ Med; 1998 Feb; 69(2):166-71. PubMed ID: 9491258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H1-antihistamines and the central nervous system.
    Welch MJ; Meltzer EO; Simons FE
    Clin Allergy Immunol; 2002; 17():337-88. PubMed ID: 12113223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective antihistamine side effects are mitigated by evening dosing of hydroxyzine.
    Goetz DW; Jacobson JM; Apaliski SJ; Repperger DW; Martin ME
    Ann Allergy; 1991 Oct; 67(4):448-54. PubMed ID: 1683192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
    Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A
    Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
    Salmun LM; Gates D; Scharf M; Greiding L; Ramon F; Heithoff K
    Clin Ther; 2000 May; 22(5):573-82. PubMed ID: 10868555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use.
    Tashiro M; Horikawa E; Mochizuki H; Sakurada Y; Kato M; Inokuchi T; Ridout F; Hindmarch I; Yanai K
    Hum Psychopharmacol; 2005 Oct; 20(7):501-9. PubMed ID: 16086364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral H1-blockade effect of fexofenadine.
    Simons FE; Simons KJ
    Ann Allergy Asthma Immunol; 1997 Dec; 79(6):530-2. PubMed ID: 9433369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.